Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007

Ten emerging areas of neuroscience that will impact the future of

treatments for brain and nervous system

Nov 02, 2007, 01:00 ET from The Neurotechnology Industry Organization

    SAN FRANCISCO, Nov. 2 /PRNewswire/ -- The Neurotechnology Industry
 Organization (NIO) today announced the top ten emerging areas of
 neuroscience that will impact the future of treatments for brain and
 nervous system. According to NIO, the trade association that represents the
 500 companies worldwide developing treatments for the brain and nervous
 system, the U.S. economic burden of brain-related disorders has reached
 more than $1 trillion, highlighting the acute need for continued
 neuroscience research and therapeutic development.
     "Advances across a wide spectrum of neuroscience research are making
 possible the development of more effective treatments for the nearly 100
 million Americans and 2 billion people worldwide that currently suffer from
 brain-related illnesses," said Zack Lynch, Executive Director of NIO.
     Top 10 Trends of 2007:
     1.  Advancing discovery tools underpin innovation: Beyond biochips and
         brain imaging, recent advances in neuroinformatics, image-based neural
         circuit analysis, and neural computation are accelerating the pace of
         neuroscientific discovery beyond what was imagined a decade ago.
     2.  Neuroimmunology leading to new treatment targets:  The discovery that
         immune molecules play a crucial role in shaping neuronal connections
         opens up new treatment targets for Alzheimer's, autism, ALS,
         Parkinson's, schizophrenia, and nerve injury.
     3.  National Neurotechnology Initiative: Momentum for the new $200M/year
         federal R&D initiative aimed at accelerating translational neurotech
         innovation and improving the effectiveness of FDA review process for
         neuroscience drugs, devices and diagnostics grows.
     4.  Neurodevice interfaces improve prosthetics and treatments: Advanced
         brain-machine interfaces (BMI) enable the severely handicapped to
         independently compose e-mails and operate a TV in their homes. Other
         neurodevices provide functional stimulation for the treatment of pain,
         Parkinson's, obesity, and psychiatric disorders.
     5.  Addiction advances: New research clarifies the role of drugs on sleep,
         cocaine's potency, and the brain changes that occur due to abuse
         leading to new treatment strategies for this epidemic impacting over
         1.1 billion worldwide.
     6.  Normal aging brain gets more attention: More research and development
         is being focused on thinking impairments that only partially limit
         independence and quality of life for senior citizens, adults and
         school aged children. Neurosoftware will penetrate nursing homes and
         schools, as brain fitness software becomes new first-line treatment
     7.  Regenerating the spinal cord: New experimental therapies in
         development could open the doors for research to improve treatments
         for people with spinal cord injuries, brain injuries, stroke, and
         other severe movement disorders
     8.  Prevention evidence grows: You are what you eat; smoking is as bad as
         we thought; and new studies reveal the effects of environmental
         substances on Alzheimer's disease, Parkinson's disease and others.
     9.  Emotional disorders research advances:  New research continues to link
         neurogenesis to treatment of depression.  A better understanding of
         PTSD should lead to new treatment regimes.
     10. Neuroscience infiltrates society: From neuroeconomics to
         neuroesthetics to neuroethics and neurolaw, the influence of
         neuroscience on society continues to grow.
     NIO has developed this "top ten" list in anticipation of cutting edge
 research being presented at The Society for Neuroscience Conference being
 held in San Diego, California, November 3-7. NIO will be hosting a booth
 (#4311) and neurotech industry partnering social at the conference.
     About the Neurotechnology Industry Organization
     The Neurotechnology Industry Organization (NIO) is the trade
 association representing companies involved in neuroscience -- drugs,
 devices and diagnostics, brain research centers, and advocacy groups across
 the world. More information can be found at
     Zack Lynch
     Neurotechnology Industry Organization
     Ross Gillfillan
     Feinstein Kean Healthcare

SOURCE The Neurotechnology Industry Organization